Mallinckrodt secures FDA approval — but not without warning; Rhythm seeks $100M after regulatory OKs
Mallinckrodt just received an FDA thumbs-up.
The American-Irish pharma said Thursday that the regulatory agency approved its injection terlipressin, now marketed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
